ENGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends October 31Also trades as ENGNW
enGene Therapeutics Inc.
Financials through Q3 FY2026, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 8, 2026
$1.58−0.09 (-5.39%)
Close on Oct 19, 2026
- Market cap
- $110.18M
- P/E (TTM)
- 0.7
- Dividend yield
- 0.00%
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
38M
Shares held, 13F filers
Institutional holders
56
55 new, 1 sold out
Net institutional buying
38M
In Q2 2026
Insider trades, 12 months
1 buys · 0 sales
Net bought $10.05K
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Forbion Growth Management B.V. | 9,201,434 | 17.20% | 13D (active) amendment | Oct 30, 2024 |
| Perceptive Advisors LLC | 6,899,803 | 9.99% | 13G (passive) amendment | Jun 30, 2026 |
| Joseph Edelman | 6,770,605 | 9.99% | 13G (passive) | Nov 11, 2025 |
| BML Investment Partners, L.P. | 6,669,908 | 9.95% | 13G (passive) amendment | May 12, 2026 |
| Raymond Debbane | 6,256,662 | 9.30% | 13G (passive) amendment | Jun 30, 2026 |
| VHCP Management III, LLC | 5,046,414 | 9.90% | 13G (passive) amendment | Dec 31, 2024 |
| Kynam Capital Management, LP | 4,994,090 | 9.80% | 13G (passive) | Dec 31, 2024 |
| Venrock Healthcare Capital Partners EG, L.P. | 4,771,414 | 7.10% | 13G (passive) amendment | Dec 31, 2025 |
| Benjamin Rovinski | 4,181,853 | 9.60% | 13D (active) amendment | Feb 20, 2024 |
| Cormorant Asset Management, LP | 4,000,000 | 5.97% | 13G (passive) | Dec 31, 2025 |
| Forbion Capital Fund III Coöperarief U.A | 3,369,275 | – | 13G (passive) amendment | Dec 31, 2023 |
| Anders Hove | 3,357,282 | 5.00% | 13G (passive) | Jul 20, 2026 |
| Bvf Partners L P/Il | 3,051,439 | 5.90% | 13G (passive) amendment | Dec 31, 2024 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of ENGN | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| BML Capital Management, LLC | 6,669,908 | – | $11.54M | New | 6.55% |
| Siren, L.L.C. | 6,256,662 | – | $10.82M | New | 0.22% |
| Perceptive Advisors LLC | 4,822,169 | – | $8.34M | New | 0.13% |
| Ameriprise Financial Inc | 2,675,876 | – | $4.63M | New | 0.00% |
| Nextech Invest, Ltd. | 2,324,943 | – | $4.02M | New | 0.19% |
| ADAR1 Capital Management, LLC | 2,104,986 | – | $3.64M | New | 0.17% |
| Vestal Point Capital, LP | 1,667,430 | – | $2.88M | New | 0.07% |
| Acorn Capital Advisors, LLC | 1,271,257 | – | $2.20M | New | 0.60% |
| Peapod Lane Capital LLC | 1,102,149 | – | $1.91M | New | 1.29% |
| Balyasny Asset Management L.P. | 1,007,344 | – | $1.74M | New | 0.00% |
| Millennium Management LLC | 966,627 | – | $1.67M | New | 0.00% |
| Renaissance Technologies LLC | 829,700 | – | $1.44M | New | 0.00% |
| Citadel Advisors LLC | 717,686 | – | $1.24M | New | 0.00% |
| Affinity Asset Advisors, LLC | 600,000 | – | $1.04M | New | 0.05% |
| UBS Group AG | 509,087 | – | $880.72K | New | 0.00% |
| Eversept Partners, LP | 469,584 | – | $812.38K | New | 0.04% |
| Kynam Capital Management, LP | 457,855 | – | $792.09K | New | 0.04% |
| Seven Fleet Capital Management LP | 411,065 | – | $711.14K | New | 0.12% |
| Jane Street Group, LLC | 382,459 | – | $661.65K | New | 0.00% |
| Rangeley Capital, LLC | 305,102 | – | $527.83K | New | 0.48% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|
| Q2 2026 | 56 | 38M | 55 / 0 | 0 / 1 | 38M | 0M |
| Q1 2026 | 2 | 0M | 2 / 0 | 0 / 0 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of ENGN | Value | % of fund | As of |
|---|---|---|---|---|---|
| Fidelity Nasdaq Composite Index Fund | 40,733 | – | $75.36K | 0.00% | May 31, 2026 |
| Tiff Multi-Asset Fund | 10,639 | – | $18.41K | 0.00% | Jun 30, 2026 |
| JNL/DFA U.S. Small Cap Fund | 9,974 | – | $17.26K | 0.00% | Jun 30, 2026 |
| North Square Kennedy Microcap Fund | 7,649 | – | $14.15K | 0.04% | May 31, 2026 |
| AST Small-Cap Equity Portfolio | 1,376 | – | $2.38K | 0.00% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | Latest filing |
|---|---|---|---|
| William Grossman | Interim Chief Medical Officer, Director | 5,102 | Sep 24, 2026 |
| Ronald Harold Wilfred Cooper | CEO & President, Director | 10,000 | Feb 3, 2026 |
| Constantine Chinoporos | Interim Chief Business Officer | – | Jul 22, 2026 |
| Kathleen P. Richton | SVP, Finance and Treasurer | 6,900 | Jul 22, 2026 |
| Alexander Julian Nichols | Chief Strategy & Ops. Ofc | – | Feb 3, 2026 |
| Jill Buck | Chief Development Officer | – | Feb 3, 2026 |
| Anthony Tzeyew Cheung | Chief Scientific Officer | 102,873 | Feb 3, 2026 |
| D. Ryan Daws | Chief Financial Officer | – | Feb 3, 2026 |
| Lee Giguere | Chief Legal Ofc. and Corp Secy | – | Feb 3, 2026 |
| Joan Connolly | Chief Technology Officer | – | Feb 3, 2026 |
| Matthew Ross Boyd | Chief Regulatory Officer | 7,500 | Feb 3, 2026 |
| Hussein Sweiti | Chief Medical Officer | – | Oct 1, 2025 |
| Amy Pott | Chief Global Comm. Ofc. | – | Jun 16, 2025 |
| Raj Som Pruthi | Chief Medical Officer | – | Jan 31, 2025 |
| Philip Astley-Sparke | Director | 20,000 | Jun 17, 2026 |
| Michael Thomas Heffernan | Director | – | Jun 17, 2026 |
| Richard M. Glickman | Director | 24,675 | Jun 17, 2026 |
| Lota S. Zoth | Director | – | Jun 17, 2026 |
| Wouter Joustra | Director | – | Jun 17, 2026 |
| Gerald A. Brunk | Director | 238,851 | Jun 17, 2026 |
| Paul J. Hastings | Director | – | Jun 17, 2026 |
| Jasper Bos | Director | – | Jun 16, 2025 |
| Growth Management B.V. Forbion | 10% owner | 6,798,362 | Nov 1, 2024 |
| Growth Opportunities Fund I. Cooperatief U.A. Forbion | 10% owner | 8,236,565 | Nov 1, 2024 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| William Grossman Interim Chief Medical Officer, Director | Sep 22, 2026 | Buy | +5,102 | $1.97 | $10.05K | 5,102 |
| Growth Management B.V. Forbion 10% owner | Oct 30, 2024 | Buy | +561,797 | $8.90 | $5.00M | 3,032,430 |
| Growth Opportunities Fund I. Cooperatief U.A. Forbion 10% owner | Oct 8, 2024 | Buy | +800 | $6.60 | $5.28K | 2,470,633 |
| Growth Opportunities Fund I. Cooperatief U.A. Forbion 10% owner | Oct 7, 2024 | Buy | +11,844 | $6.55 | $77.58K | 2,469,833 |
| Growth Opportunities Fund I. Cooperatief U.A. Forbion 10% owner | Oct 4, 2024 | Buy | +5,997 | $6.54 | $39.22K | 2,457,989 |
| Growth Opportunities Fund I. Cooperatief U.A. Forbion 10% owner | Oct 3, 2024 | Buy | +5,769 | $6.48 | $37.38K | 2,451,992 |
| Growth Opportunities Fund I. Cooperatief U.A. Forbion 10% owner | Oct 2, 2024 | Buy | +10,153 | $6.37 | $64.67K | 2,446,223 |
| Growth Opportunities Fund I. Cooperatief U.A. Forbion 10% owner | Oct 1, 2024 | Buy | +35,279 | $6.44 | $227.20K | 2,436,070 |
| Growth Opportunities Fund I. Cooperatief U.A. Forbion 10% owner | Sep 30, 2024 | Buy | +341,332 | $6.34 | $2.16M | 2,400,791 |
| Growth Opportunities Fund I. Cooperatief U.A. Forbion 10% owner | Sep 27, 2024 | Buy | +3,243 | $6.38 | $20.69K | 2,059,459 |
| Growth Opportunities Fund I. Cooperatief U.A. Forbion 10% owner | Sep 27, 2024 | Buy | +38,396 | $5.94 | $228.07K | 2,056,216 |
| Ronald Harold Wilfred Cooper Chief Executive Officer, Director | Sep 27, 2024 | Buy | +10,000 | $5.70 | $57.00K | 10,000 |
| Richard M. Glickman Director | May 28, 2024 | Option exercise | +120 | $0.89 | $107 | 24,675 |
| De Solidarite Des Travailleurs Du Quebec Fonds 10% owner | Apr 22, 2024 | Sale | −47,854 | $15.00 | $717.81K | 3,036,153 |
| De Solidarite Des Travailleurs Du Quebec Fonds 10% owner | Apr 19, 2024 | Sale | −100 | $15.00 | $1.50K | 3,084,007 |
| De Solidarite Des Travailleurs Du Quebec Fonds 10% owner | Apr 18, 2024 | Sale | −4,575 | $15.01 | $68.67K | 3,084,107 |
| Anthony Tzeyew Cheung Chief Technology Officer | Mar 18, 2024 | Option exercise | +52,940 | $0.89 | $47.12K | 102,873 |
| Capital Investment Management Inc. Lumira 10% owner | Feb 20, 2024 | Award | +644,965 | $10.00 | $6.45M | 993,651 |
| Capital Investment Management Inc. Lumira 10% owner | Feb 20, 2024 | Award | +155,035 | $10.00 | $1.55M | 238,851 |
| Gerald A. Brunk Director, 10% owner | Feb 20, 2024 | Award | +155,035 | $10.00 | $1.55M | 238,851 |
| Gerald A. Brunk Director, 10% owner | Feb 20, 2024 | Award | +644,965 | $10.00 | $6.45M | 993,651 |
| Growth Opportunities Fund I. Cooperatief U.A. Forbion 10% owner | Dec 29, 2023 | Buy | +9,620 | $9.09 | $87.45K | 2,017,820 |
| Growth Opportunities Fund I. Cooperatief U.A. Forbion 10% owner | Dec 29, 2023 | Buy | +400 | $8.30 | $3.32K | 2,008,200 |
| Growth Opportunities Fund I. Cooperatief U.A. Forbion 10% owner | Dec 28, 2023 | Buy | +5,050 | $7.69 | $38.83K | 2,007,800 |
| Growth Opportunities Fund I. Cooperatief U.A. Forbion 10% owner | Dec 27, 2023 | Buy | +2,750 | $7.17 | $19.72K | 2,002,750 |
| Anthony Tzeyew Cheung Chief Technology Officer | Oct 31, 2023 | Award | +49,933 | – | – | 49,933 |
| Gerald A. Brunk Director, 10% owner | Oct 31, 2023 | Award | +44,647 | – | – | 44,647 |
| Gerald A. Brunk Director, 10% owner | Oct 31, 2023 | Award | +348,686 | – | – | 348,686 |
| Gerald A. Brunk Director, 10% owner | Oct 31, 2023 | Award | +83,816 | – | – | 83,816 |
| Gerald A. Brunk Director, 10% owner | Oct 31, 2023 | Award | +1,341,790 | – | – | 1,341,790 |
| Gerald A. Brunk Director, 10% owner | Oct 31, 2023 | Award | +1,077,386 | – | – | 1,077,386 |
| Gerald A. Brunk Director, 10% owner | Oct 31, 2023 | Award | +152,974 | – | – | 152,974 |
| Growth Sponsor FEAC I. B.V. Forbion 10% owner | Oct 31, 2023 | Other | +130,085 | – | – | 1,503,581 |
| Growth Sponsor FEAC I. B.V. Forbion 10% owner | Oct 31, 2023 | Other | +2,262,351 | – | – | 3,765,932 |
| Richard M. Glickman Director | Oct 31, 2023 | Award | +24,555 | – | – | 24,555 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.